Opportunity
SAM #75N98026Q00281
Proteomic Analysis Services Using Olink Explore HT for Sickle Cell Disease Study
Buyer
NIH Office of Logistics and Acquisition Operations
Posted
April 29, 2026
Respond By
May 13, 2026
Identifier
75N98026Q00281
NAICS
541380, 541714
The National Heart, Lung, and Blood Institute (NHLBI) at the National Institutes of Health (NIH) is seeking specialized proteomic analysis services for a sickle cell disease research study. - Government Buyer: - National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI) - OEM Highlight: - Olink (Olink Explore HT platform is the required technology) - Vendors: - Psomagen, Inc. (identified as the intended service provider) - Products/Services Requested: - High-throughput proteomic analysis services using the Olink Explore HT platform - Proteomic profiling of over 5,400 proteins per sample - Standardized sample processing and assay execution using Olink Proximity Extension Assay (PEA) technology - Quality control and data normalization - Delivery of complete, analysis-ready datasets compatible with prior study data - Unique/Notable Requirements: - Strict requirement for compatibility with previously generated study data - Use of Olink Explore HT platform is mandatory to ensure data consistency - No specific part numbers or quantities provided, as this is a service-based procurement - Place of Performance/Delivery: - National Heart, Lung, and Blood Institute, NIH, Bethesda, MD
Description
The National Heart, Lung, and Blood Institute (NHLBI) intends to award a non-competitive purchase order for high-throughput proteomic analysis services using the Olink Explore HT platform. The requirement supports a longitudinal study investigating transthyretin (TTR) variants in sickle cell disease severity and includes quantification of over 5,400 proteins per sample. Services include standardized sample processing, assay execution, quality control, and delivery of normalized datasets compatible with previously generated study data. This notice is issued as a Notice of Intent for a non-competitive award; however, interested parties may submit capability statements demonstrating their ability to meet the Government’s requirement.